Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Your Representatives on Capitol Hill

Jane Jerrard  |  Issue: March 2007  |  March 1, 2007

This is the first in a series of articles profiling the committees of the ACR.

The ACR Government Affairs Committee has a long list of accomplishments from the past year—renewing funding for the Centers for Disease Control lupus registry, gathering congressional support for the Arthritis bill, and advocating for a simplified Medicare Part D, to name a few.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The committee—a group of dedicated volunteers, ACR staff, and a professional lobbying firm—advances rheumatology through advocacy, including advocating for government legislation and policies.

The committee is led by Joseph Flood, MD, president of Musculoskeletal Medical Specialties, Inc., and a clinical faculty member at the Ohio State University College of Medicine and Public Health in Columbus. Dr. Flood has a long history of volunteering for ACR committees.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“In the early ’90s I spent five years on the Committee for Rheumatologic Care, and for four or five years I was the one-person Practice Advocacy Subcommittee, dealing with Medicare issues. This was replaced by the Regional Advisory Council,” he says. “I joined the Government Affairs Committee for a year as a member, and I just started my third year as chair.”

Dr. Flood says he joined the committee because of his interest in public policy. “I spent 10 years in Washington, D.C., during my internship, residency, and fellowship,” he recalls. “I’d always been interested in government, and being in D.C. for those years piqued that interest.”

What the Committee Does

The Government Affairs Committee was formed in 1995; prior to that, both the ACR Committee on Rheumatologic Care and the Committee on Research had legislative affairs subcommittees. “Our mission is to represent the college and its members to the federal government and its agencies,” explains Dr. Flood. “Those agencies include CMS [Centers for Medicare & Medicaid Services], the Food and Drug Administration, the National Institutes of Health [NIH], and others.”

The committee focuses on issues that affect physicians and their patients. “We have policy statements, including increased advocacy for improving reimbursement from both government and private payers,” says Dr. Flood. “We often work in collaboration with the American Medical Association and the American College of Physicians; we try not to duplicate efforts of other medical associations, and we have representatives in both these groups.”

The committee actively promotes ACR policy statements. “We lobby Congress,” says Dr. Flood. “We’re in our second year working with Patton Boggs, a powerhouse lobbying agency. There are three people on the healthcare team there that we work with.”

Advocating on Behalf of Members and Patients

One of the big issues for the Government Affairs Committee is increasing federal funding for organizations that contribute to medical research. “We also advocate for funding for research for NIH,” says Dr. Flood. “We support a substantial increase for their budget; during the last two years, this budget has been flat and the proposed budget would keep it flat.”

Page: 1 2 3 4 | Single Page
Share: 

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:AC&RAdvocacyCongressLegislationRegulationRheumatic Disease

Related Articles

    Food Lover Dr. Joseph Flood Discusses Cooking, Shares Recipe

    June 21, 2018

    In addition to the classroom and exam room, the other room Joseph Flood, MD, enjoys spending time in is the kitchen. With a mother who worked as a local tavern cook and a policeman father who enjoyed preparing tasty meals as much as arresting bad guys, Dr. Flood, a rheumatologist at the Columbus Arthritis Center…

    PAC Progress and Challenges

    November 1, 2009

    After three years, RheumPAC has a solid start, and more work ahead of it

    Rheumatology Goes to Washington

    May 1, 2007

    Volunteers converge on Capitol Hill for the ACR’s annual Advocates for Arthritis Day

    Update on Legislation, Advocacy Efforts to Advance Rheumatology

    September 1, 2014

    Status of progess to fix sustainable growth rate physician formula, other rheumatology-related issues facing Congress

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences